"Revolutionizing Emergency Care: Aortic Occlusion Saves Lives"

A bayesian randomized clinical trial conducted at 16 major trauma centers in the UK found that the addition of resuscitative endovascular balloon occlusion of the aorta (REBOA) to standard care did not reduce, and may have increased, mortality in trauma patients with exsanguinating hemorrhage. The trial included 89 patients followed up for 90 days, and the all-cause mortality was 54% in the REBOA and standard care group compared to 42% in the standard care alone group. The findings suggest that the strategy of REBOA and standard care in the emergency department does not improve outcomes for these patients.